Actively Recruiting
Clinical Biomarker of Paclitaxel-induced Peripheral Neuropathy
Led by University of Southern Denmark · Updated on 2025-09-02
188
Participants Needed
3
Research Sites
150 weeks
Total Duration
On this page
Sponsors
U
University of Southern Denmark
Lead Sponsor
O
Odense University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Investigation of which patients treated with paclitaxel have an increased risk of developing peripheral neuropathy.
CONDITIONS
Official Title
Clinical Biomarker of Paclitaxel-induced Peripheral Neuropathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18 years
- Willing to give informed consent
- Scheduled to receive neo-adjuvant or adjuvant paclitaxel treatment
- Able to speak and understand Danish
- Diagnosed with breast cancer
- Paclitaxel nafive patients
You will not qualify if you...
- Neurodegenerative diseases such as neuropathy from other causes, previous stroke, or disc herniation
- Type 1 or 2 diabetes
- Pregnant
- Breastfeeding
- Relapse of cancer diagnosis
- Diagnosed with human immunodeficiency virus (HIV)
- Participation in other clinical trials changing paclitaxel dose or aiming to prevent neuropathic pain or reduce NFL levels (except use of cooling gloves)
- Previous treatment with neurotoxic chemotherapy
- Chronic pain from another cause
- Metastatic cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Odense University Hospital
Odense, Denmark, 5000
Actively Recruiting
2
University Hospital of Southern Denmark, Sønderborg
Sønderborg, Denmark, 6400
Actively Recruiting
3
University Hospital of Southern Denmark, Vejle
Vejle, Denmark, 7100
Actively Recruiting
Research Team
D
Ditte Bork Iversen, MSc Pharm, PhD
CONTACT
T
Tore B. Stage, Prof
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here